Atrium Therapeutics
RNA · NASDAQ
$7.98+$0.37 (+4.86%)TodayMarket closed ·
Prev close $7.61
EPS: actual vs estimate
Beat the estimate in 2 of the last 2 quarters, by 13.1% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$1.43 | -$1.18 | +17.6% |
| Q1 FY26 | -$1.06 | -$0.97 | +8.5% |
Earnings calls
- Shareholder/Analyst Call - Avidity Biosciences, Inc.
- Morgan Stanley 23rd Annual Global Healthcare Conference
- Wells Fargo 20th Annual Healthcare Conference 2025
- Cantor Global Healthcare Conference 2025
- Shareholder/Analyst Call - Avidity Biosciences, Inc.
- BofA Securities 2025 Healthcare Conference
- Shareholder/Analyst Call - Avidity Biosciences, Inc.
- Barclays 27th Annual Global Healthcare Conference 2025
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.